244 related articles for article (PubMed ID: 32497617)
1. Role of HMGB1 signaling in the inflammatory process in diabetic retinopathy.
Steinle JJ
Cell Signal; 2020 Sep; 73():109687. PubMed ID: 32497617
[TBL] [Abstract][Full Text] [Related]
2. Extract of Polygonum cuspidatum Attenuates Diabetic Retinopathy by Inhibiting the High-Mobility Group Box-1 (HMGB1) Signaling Pathway in Streptozotocin-Induced Diabetic Rats.
Sohn E; Kim J; Kim CS; Lee YM; Kim JS
Nutrients; 2016 Mar; 8(3):140. PubMed ID: 26950148
[TBL] [Abstract][Full Text] [Related]
3. High-Mobility Group Box-1 Modulates the Expression of Inflammatory and Angiogenic Signaling Pathways in Diabetic Retina.
Abu El-Asrar AM; Mohammad G; Nawaz MI; Siddiquei MM
Curr Eye Res; 2015; 40(11):1141-52. PubMed ID: 25495026
[TBL] [Abstract][Full Text] [Related]
4. Expatiating the molecular approaches of HMGB1 in diabetes mellitus: Highlighting signalling pathways via RAGE and TLRs.
Behl T; Sharma E; Sehgal A; Kaur I; Kumar A; Arora R; Pal G; Kakkar M; Kumar R; Bungau S
Mol Biol Rep; 2021 Feb; 48(2):1869-1881. PubMed ID: 33479829
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic translocation of high-mobility group box-1 protein is induced by diabetes and high glucose in retinal pericytes.
Kim J; Kim CS; Sohn E; Kim JS
Mol Med Rep; 2016 Oct; 14(4):3655-61. PubMed ID: 27599553
[TBL] [Abstract][Full Text] [Related]
6. The role of high mobility group box 1 (HMGB-1) in the diabetic retinopathy inflammation and apoptosis.
Yu Y; Yang L; Lv J; Huang X; Yi J; Pei C; Shao Y
Int J Clin Exp Pathol; 2015; 8(6):6807-13. PubMed ID: 26261566
[TBL] [Abstract][Full Text] [Related]
7. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).
van Beijnum JR; Buurman WA; Griffioen AW
Angiogenesis; 2008; 11(1):91-9. PubMed ID: 18264787
[TBL] [Abstract][Full Text] [Related]
8. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.
Ullah MA; Loh Z; Gan WJ; Zhang V; Yang H; Li JH; Yamamoto Y; Schmidt AM; Armour CL; Hughes JM; Phipps S; Sukkar MB
J Allergy Clin Immunol; 2014 Aug; 134(2):440-50. PubMed ID: 24506934
[TBL] [Abstract][Full Text] [Related]
9. High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina.
Mohammad G; Siddiquei MM; Othman A; Al-Shabrawey M; Abu El-Asrar AM
Exp Eye Res; 2013 Feb; 107():101-9. PubMed ID: 23261684
[TBL] [Abstract][Full Text] [Related]
10. HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation.
Nogueira-Machado JA; Volpe CM; Veloso CA; Chaves MM
Expert Opin Ther Targets; 2011 Aug; 15(8):1023-35. PubMed ID: 21585289
[TBL] [Abstract][Full Text] [Related]
11. Cross-Talk between Sirtuin 1 and the Proinflammatory Mediator High-Mobility Group Box-1 in the Regulation of Blood-Retinal Barrier Breakdown in Diabetic Retinopathy.
Mohammad G; Abdelaziz GM; Siddiquei MM; Ahmad A; De Hertogh G; Abu El-Asrar AM
Curr Eye Res; 2019 Oct; 44(10):1133-1143. PubMed ID: 31136205
[No Abstract] [Full Text] [Related]
12. RAGE silencing deters CML-AGE induced inflammation and TLR4 expression in endothelial cells.
Ramya R; Coral K; Bharathidevi SR
Exp Eye Res; 2021 May; 206():108519. PubMed ID: 33639133
[TBL] [Abstract][Full Text] [Related]
13. Interplay between RAGE and TLR4 Regulates HMGB1-Induced Inflammation by Promoting Cell Surface Expression of RAGE and TLR4.
Zhong H; Li X; Zhou S; Jiang P; Liu X; Ouyang M; Nie Y; Chen X; Zhang L; Liu Y; Tao T; Tang J
J Immunol; 2020 Aug; 205(3):767-775. PubMed ID: 32580932
[TBL] [Abstract][Full Text] [Related]
14. High-mobility group box 1 inhibits HCO(3)(-) absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway.
Good DW; George T; Watts BA
Am J Physiol Renal Physiol; 2015 Oct; 309(8):F720-30. PubMed ID: 26180239
[TBL] [Abstract][Full Text] [Related]
15. Blockade of HMGB1 Attenuates Diabetic Nephropathy in Mice.
Chen X; Ma J; Kwan T; Stribos EGD; Messchendorp AL; Loh YW; Wang X; Paul M; Cunningham EC; Habib M; Alexander IE; Sharland AF; Chadban SJ; Wu H
Sci Rep; 2018 May; 8(1):8319. PubMed ID: 29844451
[TBL] [Abstract][Full Text] [Related]
16. Involvement of HMGB1 mediated signalling pathway in diabetic retinopathy: evidence from type 2 diabetic rats and ARPE-19 cells under diabetic condition.
Chen XL; Zhang XD; Li YY; Chen XM; Tang DR; Ran RJ
Br J Ophthalmol; 2013 Dec; 97(12):1598-603. PubMed ID: 24133029
[TBL] [Abstract][Full Text] [Related]
17. HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo.
Jiang S; Chen X
Drug Des Devel Ther; 2017; 11():783-795. PubMed ID: 28352154
[TBL] [Abstract][Full Text] [Related]
18. High-Mobility Group Box 1 Protein Signaling in Painful Diabetic Neuropathy.
Thakur V; Sadanandan J; Chattopadhyay M
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019145
[TBL] [Abstract][Full Text] [Related]
19. High-Mobility Group Box-1 Protein Mediates the Regulation of Signal Transducer and Activator of Transcription-3 in the Diabetic Retina and in Human Retinal Müller Cells.
Mohammad G; Jomar D; Siddiquei MM; Alam K; Abu El-Asrar AM
Ophthalmic Res; 2017; 57(3):150-160. PubMed ID: 27560926
[TBL] [Abstract][Full Text] [Related]
20. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4.
Nadatani Y; Watanabe T; Tanigawa T; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
Am J Pathol; 2012 Jul; 181(1):98-110. PubMed ID: 22634181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]